Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to -$185.9 million.

  • IDEAYA Biosciences' Net Cash Flow rose 4117.55% to -$185.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.7 million, marking a year-over-year increase of 13947.68%. This contributed to the annual value of $28.7 million for FY2025, which is 13947.68% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Net Cash Flow stood at -$185.9 million for Q4 2025, which was up 4117.55% from $184.3 million recorded in Q3 2025.
  • IDEAYA Biosciences' Net Cash Flow's 5-year high stood at $217.2 million during Q3 2024, with a 5-year trough of -$316.0 million in Q4 2024.
  • Moreover, its 5-year median value for Net Cash Flow was $1.9 million (2023), whereas its average is $2.1 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Net Cash Flow soared by 453906.81% in 2021 and then crashed by 617363.06% in 2024.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Net Cash Flow stood at -$16.4 million in 2021, then tumbled by 103.41% to -$33.3 million in 2022, then skyrocketed by 115.61% to $5.2 million in 2023, then tumbled by 6173.63% to -$316.0 million in 2024, then soared by 41.18% to -$185.9 million in 2025.
  • Its Net Cash Flow was -$185.9 million in Q4 2025, compared to $184.3 million in Q3 2025 and -$15.4 million in Q2 2025.